...
search icon
kmda-img

Kamada Share Price

KMDA
NSQ
$8.57
+$0.06
(0.71%)
1D
Industry: Biotechnology Sector: Health Care

Kamada Analyst Forecast

Kamada Share Price Chart

Kamada Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$490.87M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
24.3143
Volume info-icon
This is the total number of shares traded during the most recent trading day.
208.76K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
3%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.29
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.54 L
$8.88 H
$8.57

About Kamada, Common Stock

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. more

Industry: BiotechnologySector: Health Care

Kamada Stock Returns

Time FrameKMDASectorS&P500
1-Week Return6.86%0.91%2.13%
1-Month Return6.33%-0.72%-0.47%
3-Month Return17.72%2.24%1.29%
6-Month Return14.57%19.1%7.71%
1-Year Return5.93%7.15%14.7%
3-Year Return103.08%16.96%67.75%
5-Year Return22.78%33.23%76.25%
10-Year Return144.16%142.74%271.83%

Kamada Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue133.25M103.64M129.34M142.52M160.95M[{"date":"2020-12-31","value":82.79,"profit":true},{"date":"2021-12-31","value":64.39,"profit":true},{"date":"2022-12-31","value":80.36,"profit":true},{"date":"2023-12-31","value":88.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue85.69M73.31M82.64M87.03M90.99M[{"date":"2020-12-31","value":94.18,"profit":true},{"date":"2021-12-31","value":80.58,"profit":true},{"date":"2022-12-31","value":90.82,"profit":true},{"date":"2023-12-31","value":95.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit47.55M30.33M46.70M55.49M69.97M[{"date":"2020-12-31","value":67.96,"profit":true},{"date":"2021-12-31","value":43.35,"profit":true},{"date":"2022-12-31","value":66.75,"profit":true},{"date":"2023-12-31","value":79.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin35.69%29.26%36.11%38.94%43.47%[{"date":"2020-12-31","value":82.1,"profit":true},{"date":"2021-12-31","value":67.32,"profit":true},{"date":"2022-12-31","value":83.07,"profit":true},{"date":"2023-12-31","value":89.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses28.32M31.02M42.17M45.43M49.92M[{"date":"2020-12-31","value":56.73,"profit":true},{"date":"2021-12-31","value":62.15,"profit":true},{"date":"2022-12-31","value":84.48,"profit":true},{"date":"2023-12-31","value":91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income19.24M(696.00K)4.53M10.06M20.05M[{"date":"2020-12-31","value":95.94,"profit":true},{"date":"2021-12-31","value":-3.47,"profit":false},{"date":"2022-12-31","value":22.6,"profit":true},{"date":"2023-12-31","value":50.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense89.00K(2.17M)(7.61M)(2.35M)(5.26M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2439.33,"profit":false},{"date":"2022-12-31","value":-8555.06,"profit":false},{"date":"2023-12-31","value":-2634.83,"profit":false},{"date":"2024-12-31","value":-5908.99,"profit":false}]
Pre-Tax Income18.57M(1.89M)(2.26M)8.43M13.33M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-10.15,"profit":false},{"date":"2022-12-31","value":-12.17,"profit":false},{"date":"2023-12-31","value":45.4,"profit":true},{"date":"2024-12-31","value":71.82,"profit":true}]
Income Taxes1.43M345.00K62.00K145.00K(1.13M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":24.21,"profit":true},{"date":"2022-12-31","value":4.35,"profit":true},{"date":"2023-12-31","value":10.18,"profit":true},{"date":"2024-12-31","value":-79.16,"profit":false}]
Income After Taxes17.14M(2.23M)(2.32M)8.28M14.46M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.01,"profit":false},{"date":"2022-12-31","value":-13.54,"profit":false},{"date":"2023-12-31","value":48.33,"profit":true},{"date":"2024-12-31","value":84.38,"profit":true}]
Income From Continuous Operations17.14M(2.23M)(2.32M)8.28M14.46M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.01,"profit":false},{"date":"2022-12-31","value":-13.54,"profit":false},{"date":"2023-12-31","value":48.33,"profit":true},{"date":"2024-12-31","value":84.38,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income17.14M(2.23M)(2.32M)8.28M14.46M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.01,"profit":false},{"date":"2022-12-31","value":-13.54,"profit":false},{"date":"2023-12-31","value":48.33,"profit":true},{"date":"2024-12-31","value":84.38,"profit":true}]
EPS (Diluted)0.39(0.05)(0.05)0.150.26[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-12.82,"profit":false},{"date":"2022-12-31","value":-12.82,"profit":false},{"date":"2023-12-31","value":38.46,"profit":true},{"date":"2024-12-31","value":66.67,"profit":true}]

Kamada Ratios

Kamada Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

KMDA
Cash Ratio 1.51
Current Ratio 4.03
Quick Ratio 2.24

Kamada Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KMDA
ROA (LTM) 4.76%
ROE (LTM) 7.86%

Kamada Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KMDA
Debt Ratio Lower is generally better. Negative is bad. 0.30
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

Kamada Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KMDA
Trailing PE 24.31
Forward PE 18.94
P/S (TTM) 2.81
P/B 1.82
Price/FCF 72
EV/R 2.36
EV/Ebitda 11.09
PEG 0.74

FAQs

What is Kamada share price today?

Kamada (KMDA) share price today is $8.57

Can Indians buy Kamada shares?

Yes, Indians can buy shares of Kamada (KMDA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KMDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kamada be purchased?

Yes, you can purchase fractional shares of Kamada (KMDA) via the Vested app. You can start investing in Kamada (KMDA) with a minimum investment of $1.

How to invest in Kamada shares from India?

You can invest in shares of Kamada (KMDA) via Vested in three simple steps:

  • Click on Sign Up or Invest in KMDA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kamada shares
What is Kamada 52-week high and low stock price?

The 52-week high price of Kamada (KMDA) is $8.88. The 52-week low price of Kamada (KMDA) is $5.54.

What is Kamada price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kamada (KMDA) is 24.3143

What is Kamada price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kamada (KMDA) is 1.82

What is Kamada dividend yield?

The dividend yield of Kamada (KMDA) is 3%

What is the Market Cap of Kamada?

The market capitalization of Kamada (KMDA) is $490.87M

What is Kamada's stock symbol?

The stock symbol (or ticker) of Kamada is KMDA

How Can Investors Use Kamada Share Price Data for Long-Term Investment Decisions?

Consider the share price of Kamada as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Kamada has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Kamada shares for Indian investors?

When investing in Kamada shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Kamada stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Kamada share price with other stocks in the same sector?

Rather than merely checking the share price of Kamada and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Kamada stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top